NCT01721967

Ranolazine for the Treatment of Chest Pain in HCM Patients

Ranolazine for the Treatment of Angina in Hypertrophic Cardiomyopathy Investigation

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 14 (actual)
• Sponsor: Duke University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of RHYME is to evaluate the safety and efficacy of ranolazine in Hypertrophic Cardiomypathy patients with chest pain or dyspnea despite treatment with standard medical therapy. This is a small, pilot, open-label (non-randomized) study of an approved drug for the treatment of angina in a novel patient population (adult patient population with hypertrophic cardiomyopathy).

Conditions

• Hypertrophic Cardiomyopathy

Interventions

Type	Name	Description
DRUG	Ranolazine

Timeline

• Start date: 2012-11-01
• Primary completion: 2015-11-01
• Completion: 2016-05-01
• First posted: 2012-11-06
• Last updated: 2017-03-03
• Results posted: 2017-01-18

Locations

1 site across 1 country: United States